We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTW icon
3501
MarketWise
MKTW
$54.4M
$36K ﹤0.01%
241
-1,602
-87% -$228K
PKBK icon
3502
Parke Bancorp
PKBK
$392M
$36K ﹤0.01%
+1,701
New +$37.1K
TAOX
3503
Tao Synergies Inc
TAOX
$25.9M
$36K ﹤0.01%
+169
New +$42.3K
SPIR icon
3504
Spire Global
SPIR
$432M
$36K ﹤0.01%
+1,317
New +$53.3K
MTOR
3505
DELISTED
MERITOR, Inc.
MTOR
$36K ﹤0.01%
1,431
-135,215
-99% -$3.45M
BTBT icon
3506
Bit Digital
BTBT
$477M
$35K ﹤0.01%
+5,567
New +$53.3K
DX
3507
Dynex Capital
DX
$3B
$35K ﹤0.01%
2,056
-294,593
-99% -$5.11M
PMCB icon
3508
PharmaCyte Biotech
PMCB
$6.28M
$35K ﹤0.01%
+13,515
New +$37.2K
VERV
3509
DELISTED
Verve Therapeutics
VERV
$35K ﹤0.01%
+939
New +$39.4K
VNTR
3510
DELISTED
Venator Materials PLC
VNTR
$35K ﹤0.01%
13,903
-24,450
-64% -$70.1K
PCSB
3511
DELISTED
PCSB Financial Corporation
PCSB
$34K ﹤0.01%
+1,735
New +$32.5K
XELA
3512
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$34K ﹤0.01%
+9
New +$52.8K
CIB icon
3513
Grupo Cibest SA
CIB
$20.9B
$33K ﹤0.01%
+1,048
New +$35.3K
KOSS icon
3514
Koss Corp
KOSS
$34.6M
$33K ﹤0.01%
+3,238
New +$48.1K
MSP
3515
DELISTED
Datto Holding Corp.
MSP
$33K ﹤0.01%
+1,217
New +$29.6K
AMCR icon
3516
Amcor
AMCR
$20.9B
$32K ﹤0.01%
+531
New +$31.5K
MASI
3517
DELISTED
Masimo
MASI
$32K ﹤0.01%
+113
New +$32.2K
MLM icon
3518
Martin Marietta Materials
MLM
$34.3B
$32K ﹤0.01%
+72
New +$29.2K
PANA
3519
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$32K ﹤0.01%
+3,442
New +$33.6K
ATR icon
3520
AptarGroup
ATR
$8.51B
$31K ﹤0.01%
+257
New +$32K
CTSO icon
3521
Cytosorbents Corp
CTSO
$22.6M
$31K ﹤0.01%
+7,627
New +$42.8K
CULP icon
3522
Culp Inc
CULP
$45.5M
$31K ﹤0.01%
+3,325
New +$38.3K
ORTX
3523
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$31K ﹤0.01%
2,355
-13,364
-85% -$221K
ALKT icon
3524
Alkami Technology
ALKT
$1.9B
$30K ﹤0.01%
1,549
-87,285
-98% -$2.24M
FABC
3525
Fabric.AI Inc
FABC
$16.8M
$30K ﹤0.01%
+147
New +$47.3K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.